Histopathological features and their prognostic impact in nodular lymphocyte-predominant Hodgkin lymphoma - a matched pair analysis from the German Hodgkin Study Group (GHSG)-Reference-Cited by-同舟云学术

Histopathological features and their prognostic impact in nodular lymphocyte-predominant Hodgkin lymphoma - a matched pair analysis from the German Hodgkin Study Group (GHSG)

Published:2014-06-26 Issue:2 Volume:167 Page:238-242
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Hartmann Sylvia¹,Eichenauer Dennis A.²³,Plütschow Annette²³,Mottok Anja⁴,Bob Roshanak⁵,Koch Karoline⁶,Bernd Heinz-Wolfram⁷,Cogliatti Sergio⁸,Hummel Michael⁹,Feller Alfred C.⁷,Ott German¹⁰,Möller Peter¹¹,Rosenwald Andreas⁴,Stein Harald⁵,Hansmann Martin-Leo¹,Engert Andreas²³,Klapper Wolfram⁶

Affiliation:

1. Dr. Senckenberg Institute of Pathology; Goethe University; Frankfurt am Main Germany

2. First Department of Internal Medicine; University Hospital of Cologne; Cologne Germany

3. German Hodgkin Study Group; University Hospital of Cologne; Cologne Germany

4. Institute of Pathology; University of Würzburg and Comprehensive Cancer Center (CCC) Mainfranken; Würzburg Germany

5. Pathodiagnostic Berlin; Berlin Reference Centre for Lymphoma and Haematopathology; Berlin Germany

6. Institute of Pathology; Haematopathology Section and Lymph Node Registry; Universitätsklinikum Schleswig-Holstein; Kiel Germany

7. Institute of Pathology; Universitätsklinikum Schleswig-Holstein; Lübeck Germany

8. Institute of Pathology; Kantonsspital St. Gallen; St. Gallen Switzerland

9. Institute of Pathology; Charité University Hospital; Berlin Germany

10. Department of Clinical Pathology; Robert-Bosch-Krankenhaus; Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology; Stuttgart Germany

11. Institute of Pathology; University Hospital Ulm; Ulm Germany

Funder

Deutsche Forschungsgemeinschaft

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12997/fullpdf

Reference15 articles.

1. Mature results of a phase II study of rituximab therapy for nodular lymphocyte-predominant Hodgkin lymphoma;Advani;Journal of Clinical Oncology,2014

2. VII. Management of nodular lymphocyte-predominant Hodgkin lymphoma;Eichenauer;Hematological Oncology,2013

3. Phase 2 study of rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group;Eichenauer;Blood,2011

4. Characterization of variant patterns of nodular lymphocyte predominant Hodgkin lymphoma with immunohistologic and clinical correlation;Fan;American Journal of Surgical Pathology,2003

5. The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG);Hartmann;Blood,2013a

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of immunoarchitectural patterns on clinical presentation and response to therapy in children with nodular lymphocyte predominant Hodgkin lymphoma;Pediatric Hematology/Oncology and Immunopathology;2024-04-15

2. IgD expression in various immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma in children;Arkhiv patologii;2024

3. Variant histology of pediatric nodular lymphocyte‐predominant Hodgkin lymphoma with IgD and CD30 expression;Pediatric Blood & Cancer;2023-08-28

4. Cobalt oxide modified sulfur and phosphorus Co-doped g-C3N4 for screening of urinary human albumin;Microchimica Acta;2023-08-18

5. The spectrum of nodular lymphocyte predominant Hodgkin lymphoma: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology;Virchows Archiv;2023-08-02